Bhavesh Ashar, Chief Commercial Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 14,557 shares at $44.31 ($694K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Open-market sale of $694k SWTX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.75 | 1,089 | $48K | 6.9% |
| 2 | $44.31 | 1,667 | $74K | 10.6% |
| 3 | $44.31 | 1,667 | $74K | 10.6% |
| 4 | $46.00 | 378 | $17K | 2.5% |
| 5 | $46.37 | 88 | $4K | 0.6% |
| 6 | $49.32 | 4,834 |
| $238K |
| 34.4% |
| 7 | $49.32 | 4,834 | $238K | 34.4% |
| Total | $47.65 avg | 14,557 | $694K | 100% |